Corcept Therapeutics Director James N. Wilson Reports Sale of $1.15 Million in Common Shares
Corcept Therapeutics director James N. Wilson sold 10,000 common shares on Oct. 15, 2026. Sales comprised 6,654 shares at $114.4751, 3,046 at $115.3895 and 300 at $116.2967. The James N. Wilson and Pamela D. Wilson Trust held 1,054,543 common shares following the sales. Two grantor retained annuity trusts held another